Attentional set-shifting in rodents: A review of behavioural methods and pharmacological results

Current Pharmaceutical Design

Volumn 20, Issue 31, 2014, Pages 5046-5059

  Tait, David S ^a   Chase, E Alexander ^a   Brown, Verity J ^a  

^a UNIVERSITY OF ST ANDREWS   (United Kingdom)

Author keywords

Attentional set shifting; Mouse; Rat; Reversal learning; Schizophrenia

Indexed keywords

ACETYLCHOLINE; AMPHETAMINE; ATIPAMEZOLE; DESIPRAMINE; DOPAMINE; KETAMINE; METHAMPHETAMINE; METHYLAZOXYMETHANOL ACETATE; NEUROTRANSMITTER; NORADRENALIN; PHENCYCLIDINE; SCOPOLAMINE; SEROTONIN; BIOGENIC AMINE;

ANTERIOR CINGULATE; ATTENTIONAL SET SHIFTING; CINGULATE GYRUS; COGNITION; COGNITIVE DEFECT; DOPAMINERGIC SYSTEM; DORSAL NORADRENERGIC BUNDLE; EXPERIMENTAL TEST; FOREBRAIN; HUMAN; LEARNING; NEUROPATHOLOGY; NEUROTRANSMISSION; NONHUMAN; POSTERIOR PARIETAL CORTEX; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT; REVIEW; SCHIZOPHRENIA; TASK PERFORMANCE; ALZHEIMER DISEASE; ARTICLE; ATTENTION; ATTENTION DEFICIT DISORDER; EXECUTIVE FUNCTION; FRONTAL CORTEX; HUNTINGTON CHOREA; PARKINSON DISEASE; RODENT; ANIMAL; COGNITION DISORDERS; COMPLICATION; DISEASE MODEL; DRUG EFFECTS; PATHOPHYSIOLOGY; PERCEPTIVE DISCRIMINATION; PHYSIOLOGY; PSYCHOLOGY;

ANIMALS; ATTENTION; BIOGENIC AMINES; COGNITION DISORDERS; DISCRIMINATION (PSYCHOLOGY); DISEASE MODELS, ANIMAL; HUMANS; PREFRONTAL CORTEX; REVERSAL LEARNING; RODENTIA; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY;

EID: 84906238933     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/1381612819666131216115802     Document Type: Review

References (143)

1. Vigotsky LS, Kasanin JJ. Thought in schizophrenia. Archives Neurol Psychiatry 1934; 31: 1063-1077.
2. Berg EA. A simple objective technique for measuring flexibility in thinking. J Gen Psych 1948; 39: 15-22.
3. Grant DA, Berg EA. A behavioral analysis of degree of reinforcement and ease of shifting to new responses in a Weigl-type card-sorting problem. J Exp Psychol 1948; 38: 404-411.
4. Brown VJ, Tait DS. Behavioral Flexibility: Attentional Shifting, Rule Switching and Response Reversal. In: Stolerman IP, ed., Encyclopedia of Psychopharmacology. Springer 2010.
5. Barcelo F, Knight RT. Both random and perseverative errors underlie WCST deficits in prefrontal patients. Neuropsychologia 2002; 40: 349-356.
6. Demakis GJ. A meta-analytic review of the sensitivity of the Wisconsin Card Sorting Test to frontal and lateralized frontal brain damage. Neuropsychology, 2003; 17: 255-264.
7. Milner B. Effect of different brain lesions on card sorting. Arch Neurol 1963; 9: 90-100.
8. Ridderinkhof KR, Span MM, van der Molen MW. Perseverative behavior and adaptive control in older adults: performance monitoring, rule induction, and set shifting. Brain Cogn 2002; 49: 382-401.
9. West RL. An application of prefrontal cortex function theory to cognitive aging. Psychol Bull 1996; 120: 272-292.
10. Paolo AM, Troster AI, Axelrod BN, Koller WC. Construct validity of the WCST in normal elderly and persons with Parkinson's disease. Arch Clin Neuropsychol 1995; 10: 463-473.
11. Nagahama Y, Okina T, Suzuki N, Nabatame H, Matsuda M. The cerebral correlates of different types of perseveration in the Wisconsin Card Sorting Test. J Neurol Neurosurg Psychiatry 2005; 76: 169-175.
12. Romine CB, Lee D, Wolfe ME, Homack S, George C, Riccio CA. Wisconsin Card Sorting Test with children: a meta-analytic study of sensitivity and specificity. Arch Clin Neuropsychol 2004; 19: 1027-1041.
13. Nieuwenstein MR, Aleman A, de Haan EH. Relationship between symptom dimensions and neurocognitive functioning in schizophrenia: a meta-analysis of WCST and CPT studies. Wisconsin Card Sorting Test. Continuous Performance Test. J Psychiatr Res 2001; 35: 119-125.
14. Weinberger DR. Schizophrenia and the frontal lobe. Trends Neuro-sci 1988; 11: 367-370.
15. Weinberger DR, Berman KF, Zec RF. Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia. I. Regional cerebral blood flow evidence. Arch Gen Psychiatry 1986; 43: 114-124.
16. Goldberg TE, Weinberger DR, Berman KF, Pliskin NH, Podd MH. Further evidence for dementia of the prefrontal type in schizophrenia? A controlled study of teaching the Wisconsin Card Sorting Test. Arch Gen Psychiatry 1987; 44: 1008-1014.
17. Elliott R, McKenna PJ, Robbins TW, Sahakian BJ. Neuropsy-chological evidence for frontostriatal dysfunction in schizophrenia. Psychol Med 1995; 25: 619-630.
18. Ragozzino ME, Wilcox C, Raso M, Kesner RP. Involvement of rodent prefrontal cortex subregions in strategy switching. Behav Neurosci 1999; 113: 32-41.
19. Lawrence DH. Acquired distinctiveness of cues; transfer between discrimination on the basis of familiarity with the stimulus. J Exp Psychol 1949; 39: 770-784.
20. Settlage P, Butler R, Odoi H. Perseverative interface in monkeys following bilateral removal of the prefrontal areas. J Gen Psych 1956; 54: 255-262.
21. Eimas PD. Effects of overtraining and age on intradimensional and extradimensional shifts in children. J Exp Child Psychol 1966; 3: 348-355.
22. Owen AM, Roberts AC, Polkey CE, Sahakian BJ, Robbins TW. Extra- dimensional versus intra-dimensional set shifting performance following frontal lobe excisions, temporal lobe excisions or amygdalo-hippocampectomy in man. Neuropsychologia 1991; 29: 993-1006.
23. Roberts AC, Robbins TW, Everitt BJ. The effects of intradimen-sional and extradimensional shifts on visual discrimination learning in humans and non- human primates. Q J Exp Psychol B 1988; 40: 321-341.
24. Shepp BE, Schrier AM. Consecutive intradimensional and extradi-mensional shifts in monkeys. J Comp Physiol Psychol 1969; 67: 199-203.
25. Sutherland NS, Mackintosh NJ. Mechanisms of animal discrimination learning. Academic Press: New York 1971.
26. Slamecka NJ. A methodological analysis of shift paradigms in human discrimination learning. Psychol Bull 1968; 69: 423-438.
27. Gibson JJ. A critical review of the concept of set in contemporary experimental psychology. Psychological Bulletin 1941; 38: 781-817.
28. Sahakian BJ, Owen AM. Computerized assessment in neuropsy-chiatry using CANTAB: discussion paper. J R Soc Med 1992; 85: 399-402.
29. Roberts AC, De Salvia MA, Wilkinson LS, et al. 6-Hydroxydopamine lesions of the prefrontal cortex in monkeys enhance performance on an analog of the Wisconsin Card Sort Test: possible interactions with subcortical dopamine. J Neurosci 1994; 14: 2531-2544.
30. Dias R, Robbins TW, Roberts AC. Dissociation in prefrontal cortex of affective and attentional shifts. Nature 1996; 380: 69-72.
31. Dias R, Robbins TW, Roberts AC. Dissociable forms of inhibitory control within prefrontal cortex with an analog of the Wisconsin Card Sort Test: restriction to novel situations and independence from on-line processing. J Neurosci 1997; 17: 9285-9297.
32. Lawrence AD, Hodges JR, Rosser AE, et al. Evidence for specific cognitive deficits in preclinical Huntington's disease. Brain 1998; 121 (Pt 7): 1329-1341.
33. Robbins TW, James M, Owen AM, et al. A study of performance on tests from the CANTAB battery sensitive to frontal lobe dysfunction in a large sample of normal volunteers: implications for theories of executive functioning and cognitive aging. Cambridge Neuropsychological Test Automated Battery. J Int Neuropsychol Soc 1998; 4: 474-490.
34. Leeson VC, Robbins TW, Matheson E, et al. Discrimination learning, reversal, and set-shifting in first-episode schizophrenia: stability over six years and specific associations with medication type and disorganization syndrome. Biol Psychiatry 2009; 66: 586-593.
35. Chamberlain SR, Robbins TW, Winder-Rhodes S, et al. Transla-tional approaches to frontostriatal dysfunction in attention-deficit/hyperactivity disorder using a computerized neuropsy-chological battery. Biol Psychiatry 2011; 69: 1192-1203.
36. Anderson AL, Li SH, Biswas K, et al. Modafinil for the treatment of methamphetamine dependence. Drug Alcohol Depend 2012; 120: 135-141.
37. Roberts AC, Robbins TW, Everitt BJ, Muir JL. A specific form of cognitive rigidity following excitotoxic lesions of the basal fore-brain in marmosets. Neuroscience 1992; 47: 251-264.
38. Dias R, Robbins TW, Roberts AC. Primate analogue of the Wisconsin Card Sorting Test: effects of excitotoxic lesions of the pre-frontal cortex in the marmoset. Behav Neurosci 1996; 110: 872-886.
39. Clarke HF, Walker SC, Crofts HS, Dalley JW, Robbins TW, Roberts AC. Prefrontal serotonin depletion affects reversal learning but not attentional set shifting. J Neurosci 2005; 25: 532-538.
40. Birrell JM, Brown VJ. Medial frontal cortex mediates perceptual attentional set shifting in the rat. J Neurosci 2000; 20: 4320-4324.
41. Lashley KS. The Mechanism of Vision: I. A Method for Rapid Analysis of Pattern-Vision in the Rat. Pedagog Semin J Genet Psy-chol 1930; 37: 453-460.
42. Bussey TJ, Muir JL, Everitt BJ, Robbins TW. Triple dissociation of anterior cingulate, posterior cingulate, and medial frontal cortices on visual discrimination tasks using a touchscreen testing procedure for the rat. Behav Neurosci 1997; 111: 920-936.
43. Brooks SP, Betteridge H, Trueman RC, Jones L, Dunnett SB. Selective extra- dimensional set shifting deficit in a knock-in mouse model of Huntington's disease. Brain Res Bull 2006; 69: 452-457.
44. Colacicco G, Welzl H, Lipp HP, Wurbel H. Attentional set-shifting in mice: modification of a rat paradigm, and evidence for strain-dependent variation. Behav Brain Res 2002; 132: 95-102.
45. Laurent V, Podhorna J. Subchronic phencyclidine treatment impairs performance of C57BL/6 mice in the attentional set-shifting task. Behav Pharmacol 2004; 15: 141-148.
46. Glickstein SB, Desteno DA, Hof PR, Schmauss C. Mice lacking dopamine D2 and D3 receptors exhibit differential activation of prefrontal cortical neurons during tasks requiring attention. Cereb Cortex 2005; 15: 1016-1024.
47. Brigman JL, Bussey TJ, Saksida LM, Rothblat LA. Discrimination of multidimensional visual stimuli by mice: intra- and extradimen-sional shifts. Behav Neurosci 2005; 119: 839-842.
48. Bissonette GB, Martins GJ, Franz TM, Harper ES, Schoenbaum G, Powell EM. Double dissociation of the effects of medial and orbital prefrontal cortical lesions on attentional and affective shifts in mice. J Neurosci 2008; 28: 11124-11130.
49. Young JW, Powell SB, Geyer MA, Jeste DV, Risbrough VB. The mouse attentional-set-shifting task: a method for assaying successful cognitive aging? Cogn Affect Behav Neurosci 2010; 10: 243-251.
50. Garner JP, Thogerson CM, Wurbel H, Murray JD, Mench JA. Animal neuropsychology: validation of the Intra-Dimensional Extra-Dimensional set shifting task for mice. Behav Brain Res 2006; 173: 53-61.
51. Papaleo F, Crawley JN, Song J, et al. Genetic dissection of the role of catechol-O-methyltransferase in cognition and stress reactivity in mice. J Neurosci 2008; 28: 8709-8723.
52. Owen AM, Roberts AC, Hodges JR, Summers BA, Polkey CE, Robbins TW. Contrasting mechanisms of impaired attentional set-shifting in patients with frontal lobe damage or Parkinson's disease. Brain 1993; 116 (Pt 5): 1159-1175.
53. Kos T, Nikiforuk A, Rafa D, Popik P. The effects of NMDA receptor antagonists on attentional set-shifting task performance in mice. Psychopharmacology (Berl) 2011; 214: 911-921.
54. Nikiforuk A, Golembiowska K, Popik P. Mazindol attenuates ketamine- induced cognitive deficit in the attentional set shifting task in rats. Eur Neuropsychopharmacol 2010; 20: 37-48.
55. Fox MT, Barense MD, Baxter MG. Perceptual attentional set-shifting is impaired in rats with neurotoxic lesions of posterior parietal cortex. J Neurosci 2003; 23: 676-681.
56. Ng CW, Noblejas MI, Rodefer JS, Smith CB, Poremba A. Double dissociation of attentional resources: prefrontal versus cingulate cortices. J Neurosci 2007; 27: 12123-12131.
57. McAlonan K, Brown VJ. Orbital prefrontal cortex mediates reversal learning and not attentional set shifting in the rat. Behav Brain Res 2003; 146: 97-103.
58. Chase EA, Tait DS, Brown VJ. Lesions of the orbital prefrontal cortex impair the formation of attentional set in rats. Eur J Neurosci 2012; 36: 2368-2375.
59. Davis KL, Kahn RS, Ko G, Davidson M. Dopamine in schizophrenia: a review and reconceptualization. Am J Psychiatry 1991; 148: 1474-1486.
60. Harrison PJ. The neuropathology of schizophrenia. A critical review of the data and their interpretation. Brain 1999; 122 (Pt 4): 593-624.
61. Parsegian A, Glen WB, Jr., Lavin A, See RE. Methamphetamine self- administration produces attentional set-shifting deficits and alters prefrontal cortical neurophysiology in rats. Biol Psychiatry 2011; 69: 253-259.
62. Izquierdo A, Belcher AM, Scott L, et al. Reversal-specific learning impairments after a binge regimen of methamphetamine in rats: possible involvement of striatal dopamine. Neuropsychopharma-cology 2010; 35: 505-514.
63. Hedou G, Homberg J, Feldon J, Heidbreder CA. Expression of sensitization to amphetamine and dynamics of dopamine neuro-transmission in different laminae of the rat medial prefrontal cortex. Neuropharmacology 2001; 40: 366-382.
64. Schwendt M, Rocha A, See RE, Pacchioni AM, McGinty JF, Kali-vas PW. Extended methamphetamine self-administration in rats results in a selective reduction of dopamine transporter levels in the prefrontal cortex and dorsal striatum not accompanied by marked monoaminergic depletion. J Pharmacol Exp Ther 2009; 331: 555-562.
65. Eisch AJ, Gaffney M, Weihmuller FB, O'Dell SJ, Marshall JF. Striatal subregions are differentially vulnerable to the neurotoxic effects of methamphetamine. Brain Res 1992; 598: 321-326.
66. Jentsch JD, Roth RH. The neuropsychopharmacology of phency-clidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia. Neuropsychopharmacology 1999; 20: 201-225.
67. Jentsch JD, Tran A, Le D, Youngren KD, Roth RH. Subchronic phencyclidine administration reduces mesoprefrontal dopamine utilization and impairs prefrontal cortical-dependent cognition in the rat. Neuropsychopharmacology 1997; 17: 92-99.
68. Jentsch JD, Redmond DE, Jr., Elsworth JD, Taylor JR, Youngren KD, Roth RH. Enduring cognitive deficits and cortical dopamine dysfunction in monkeys after long-term administration of phency-clidine. Science 1997; 277: 953-955.
69. Jentsch JD, Elsworth JD, Redmond DE, Jr., Roth RH. Phencycli-dine increases forebrain monoamine metabolism in rats and monkeys: modulation by the isomers of HA966. J Neurosci 1997; 17: 1769-1775.
70. Jentsch JD, Tran A, Taylor JR, Roth RH. Prefrontal cortical involvement in phencyclidine-induced activation of the mesolimbic dopamine system: behavioral and neurochemical evidence. Psy-chopharmacology (Berl) 1998; 138: 89-95.
71. Egerton A, Reid L, McKerchar CE, Morris BJ, Pratt JA. Impairment in perceptual attentional set-shifting following PCP administration: a rodent model of set-shifting deficits in schizophrenia. Psychopharmacology (Berl), 2005; 179: 77-84.
72. Egerton A, Reid L, McGregor S, Cochran SM, Morris BJ, Pratt JA. Subchronic and chronic PCP treatment produces temporally distinct deficits in attentional set shifting and prepulse inhibition in rats. Psychopharmacology (Berl) 2008; 198: 37-49.
73. McLean SL, Beck JP, Woolley ML, Neill JC. A preliminary investigation into the effects of antipsychotics on sub-chronic phencycli-dine-induced deficits in attentional set-shifting in female rats. Be-hav Brain Res 2008; 189: 152-158.
74. McLean SL, Idris NF, Grayson B, et al. PNU-120596, a positive allosteric modulator of alpha7 nicotinic acetylcholine receptors, reverses a sub-chronic phencyclidine- induced cognitive deficit in the attentional set-shifting task in female rats. J Psychopharmacol 2012; 26: 1265-1270.
75. Rodefer JS, Murphy ER, Baxter MG. PDE10A inhibition reverses subchronic PCP-induced deficits in attentional set-shifting in rats. Eur J Neurosci 2005; 21: 1070-1076.
76. Rodefer JS, Nguyen TN, Karlsson JJ, Arnt J. Reversal of sub-chronic PCP- induced deficits in attentional set shifting in rats by sertindole and a 5-HT6 receptor antagonist: comparison among an-tipsychotics. Neuropsychopharmacology 2008; 33: 2657-2666.
77. Fletcher PJ, Tenn CC, Rizos Z, Lovic V, Kapur S. Sensitization to amphetamine, but not PCP, impairs attentional set shifting: reversal by a D1 receptor agonist injected into the medial prefrontal cortex. Psychopharmacology (Berl) 2005; 183: 190-200.
78. Featherstone RE, Rizos Z, Kapur S, Fletcher PJ. A sensitizing regimen of amphetamine that disrupts attentional set-shifting does not disrupt working or long-term memory. Behav Brain Res 2008; 189: 170-179.
79. Deschenes A, Goulet S, Dore FY. Rule shift under long-term PCP challenge in rats. Behav Brain Res 2006; 167: 134-140.
80. Pedersen CS, Goetghebeur P, Dias R. Chronic infusion of PCP via osmotic mini-pumps: a new rodent model of cognitive deficit in schizophrenia characterized by impaired attentional set-shifting (ID/ED) performance. J Neurosci Methods 2009; 185: 66-69.
81. Snigdha S, Neill JC, McLean SL, et al. Phencyclidine (PCP)-induced disruption in cognitive performance is gender- specific and associated with a reduction in brain-derived neurotrophic factor (BDNF) in specific regions of the female rat brain. J Mol Neurosci 2011; 43: 337-345.
82. Goetghebeur P, Dias R. Comparison of haloperidol, risperidone, sertindole, and modafinil to reverse an attentional set-shifting impairment following subchronic PCP administration in the rat-a back translational study. Psychopharmacology (Berl) 2009; 202: 287-293.
83. Broberg BV, Glenthoj BY, Dias R, Larsen DB, Olsen CK. Reversal of cognitive deficits by an ampakine (CX516) and sertindole in two animal models of schizophrenia--sub-chronic and early postnatal PCP treatment in attentional set-shifting. Psychopharmacology (Berl) 2009; 206: 631-640.
84. Redrobe JP, Elster L, Frederiksen K, Bundgaard C, de Jong IE, Smith GP, Bruun AT, Larsen PH, Didriksen M. Negative modulation of GABAA alpha5 receptors by RO4938581 attenuates discrete sub-chronic and early postnatal phencyclidine (PCP)-induced cognitive deficits in rats. Psychopharmacology (Berl) 2012; 221: 451-468.
85. Wallace TL, Callahan PM, Tehim A, et al. RG3487, a novel nico-tinic alpha7 receptor partial agonist, improves cognition and sen-sorimotor gating in rodents. J Pharmacol Exp Ther 2011; 336: 242-253.
86. Goetghebeur PJ, Lerdrup L, Sylvest A, Dias R. Erythropoietin reverses the attentional set-shifting impairment in a rodent schizophrenia disease-like model. Psychopharmacology (Berl) 2010; 212: 635-642.
87. Broberg BV, Dias R, Glenthoj BY, Olsen CK. Evaluation of a neurodevelopmental model of schizophrenia--early postnatal PCP treatment in attentional set-shifting. Behav Brain Res 2008; 190: 160-163.
88. Nikiforuk A, Popik P. Effects of quetiapine and sertindole on sub-chronic ketamine-induced deficits in attentional set-shifting in rats. Psychopharmacology (Berl) 2012; 220: 65-74.
89. Featherstone RE, Rizos Z, Nobrega JN, Kapur S, Fletcher PJ. Ges-tational methylazoxymethanol acetate treatment impairs select cognitive functions: parallels to schizophrenia. Neuropsychopharma-cology 2007; 32: 483-492.
90. Flagstad P, Mork A, Glenthoj BY, van Beek J, Michael-Titus AT, Didriksen M. Disruption of neurogenesis on gestational day 17 in the rat causes behavioral changes relevant to positive and negative schizophrenia symptoms and alters amphetamine-induced dopa-mine release in nucleus accumbens. Neuropsychopharmacology 2004; 29: 2052-2064.
91. Gastambide F, Cotel MC, Gilmour G, O'Neill MJ, Robbins TW, Tricklebank MD. Selective remediation of reversal learning deficits in the neurodevelopmental MAM model of schizophrenia by a novel mGlu5 positive allosteric modulator. Neuropsychopharma-cology 2012; 37: 1057-1066.
92. Tait DS, Marston HM, Shahid M, Brown VJ. Asenapine restores cognitive flexibility in rats with medial prefrontal cortex lesions. Psychopharmacology (Berl) 2009; 202: 295-306.
93. Downes JJ, Roberts AC, Sahakian BJ, Evenden JL, Morris RG, Robbins TW. Impaired extra-dimensional shift performance in medicated and unmedicated Parkinson's disease: evidence for a specific attentional dysfunction. Neuropsychologia 1989; 27: 1329-1343.
94. Gauntlett-Gilbert J, Roberts RC, Brown VJ. Mechanisms underlying attentional set-shifting in Parkinson's disease. Neuropsycholo-gia 1999; 37: 605-616.
95. Owen AM, James M, Leigh PN, et al. Fronto-striatal cognitive deficits at different stages of Parkinson's disease. Brain 1992; 115 (Pt 6): 1727-1751.
96. Crofts HS, Dalley JW, Collins P, et al. Differential effects of 6-OHDA lesions of the frontal cortex and caudate nucleus on the ability to acquire an attentional set. Cereb Cortex, 2001; 11: 1015-1026.
97. Mattay VS, Goldberg TE, Fera F, et al. Catechol O-methyltrans-ferase val158-met genotype and individual variation in the brain response to amphetamine. Proc Natl Acad Sci USA 2003; 100: 6186-6191.
98. Vijayraghavan S, Wang M, Birnbaum SG, Williams GV, Arnsten AF. Inverted-U dopamine D1 receptor actions on prefrontal neurons engaged in working memory. Nat Neurosci 2007; 10: 376-384.
99. Zahrt J, Taylor JR, Mathew RG, Arnsten AF. Supranormal stimulation of D1 dopamine receptors in the rodent prefrontal cortex impairs spatial working memory performance. J Neurosci 1997; 17: 8528-8535.
100. Jentsch JD, Andrusiak E, Tran A, Bowers MB, Jr., Roth RH. Delta 9- tetrahydrocannabinol increases prefrontal cortical catechola-minergic utilization and impairs spatial working memory in the rat: blockade of dopaminergic effects with HA966. Neuropsychophar-macology 1997; 16: 426-432.
101. Egerton A, Brett RR, Pratt JA. Acute delta9-tetrahydrocannabinol-induced deficits in reversal learning: neural correlates of affective inflexibility. Neuropsychopharmacology 2005; 30: 1895-1905.
102. Tunbridge EM, Bannerman DM, Sharp T, Harrison PJ. Catechol-o-methyltransferase inhibition improves set-shifting performance and elevates stimulated dopamine release in the rat prefrontal cortex. J Neurosci 2004; 24: 5331-5335.
103. Berridge CW, Shumsky JS, Andrzejewski ME, et al. Differential sensitivity to psychostimulants across prefrontal cognitive tasks: differential involvement of noradrenergic alpha(1) - and alpha(2)-receptors. Biol Psychiatry 2012; 71: 467-473.
104. Cao AH, Yu L, Wang YW, Wang JM, Yang LJ, Lei GF. Effects of methylphenidate on attentional set-shifting in a genetic model of attention- deficit/hyperactivity disorder. Behav Brain Funct 2012; 8: 10.
105. Cheng JT, Li JS. Intra-orbitofrontal cortex injection of haloperidol removes the beneficial effect of methylphenidate on reversal learning of spontaneously hypertensive rats in an attentional set-shifting task. Behav Brain Res 2013; 239: 148-154.
106. Francis PT, Palmer AM, Snape M, Wilcock GK. The cholinergic hypothesis of Alzheimer's disease: a review of progress. J Neurol Neurosurg Psychiatry, 1999; 66: 137-147.
107. McGaughy J, Ross RS, Eichenbaum H. Noradrenergic, but not cholinergic, deafferentation of prefrontal cortex impairs attentional set-shifting. Neuroscience 2008; 153: 63-71.
108. Tait DS, Brown VJ. Lesions of the basal forebrain impair reversal learning but not shifting of attentional set in rats. Behav Brain Res 2008; 187: 100-108.
109. Chen KC, Baxter MG, Rodefer JS. Central blockade of muscarinic cholinergic receptors disrupts affective and attentional set-shifting. Eur J Neurosci 2004; 20: 1081-1088.
110. Medhurst AD, Atkins AR, Beresford IJ, et al. GSK189254, a novel H3 receptor antagonist that binds to histamine H3 receptors in Alzheimer's disease brain and improves cognitive performance in pre-clinical models. J Pharmacol Exp Ther 2007; 321: 1032-1045.
111. Allison C, Shoaib M. Nicotine improves performance in an atten-tional set shifting task in rats. Neuropharmacology 2013; 64: 314-320.
112. Brooks JM, Pershing ML, Thomsen MS, Mikkelsen JD, Sarter M, Bruno JP. Transient inactivation of the neonatal ventral hippocampus impairs attentional set-shifting behavior: reversal with an al-pha7 nicotinic agonist. Neuropsychopharmacology 2012; 37: 2476-2486.
113. Alexander KS, Wu HQ, Schwarcz R, Bruno JP. Acute elevations of brain kynurenic acid impair cognitive flexibility: normalization by the alpha7 positive modulator galantamine. Psychopharmacology (Berl) 2012; 220: 627-637.
114. Barense MD, Fox MT, Baxter MG. Aged rats are impaired on an attentional set-shifting task sensitive to medial frontal cortex damage in young rats. Learn Mem 2002; 9: 191-201.
115. Nieves-Martinez E, Haynes K, Childers SR, Sonntag WE, Nicolle MM. Muscarinic receptor/G-protein coupling is reduced in the dor-somedial striatum of cognitively impaired aged rats. Behav Brain Res 2012; 227: 258-264.
116. Rodefer JS, Nguyen TN. Naltrexone reverses age-induced cognitive deficits in rats. Neurobiol Aging 2008; 29: 309-313.
117. Tait DS, Chase EA, Brown VJ. Tacrine improves reversal learning in older rats. Neuropharmacology 2013; 73C: 284-289.
118. Lapiz MD, Morilak DA. Noradrenergic modulation of cognitive function in rat medial prefrontal cortex as measured by attentional set shifting capability. Neuroscience 2006; 137: 1039-1049.
119. Lapiz MD, Bondi CO, Morilak DA. Chronic treatment with de-sipramine improves cognitive performance of rats in an attentional set-shifting test. Neuropsychopharmacology 2007; 32: 1000-1010.
120. Gobert A, Rivet JM, Cistarelli L, Melon C, Millan MJ. Alpha2-adrenergic receptor blockade markedly potentiates duloxetine- and fluoxetine-induced increases in noradrenaline, dopamine, and serotonin levels in the frontal cortex of freely moving rats. J Neuro-chem 1997; 69: 2616-2619.
121. Newman LA, Darling J, McGaughy J. Atomoxetine reverses atten-tional deficits produced by noradrenergic deafferentation of medial prefrontal cortex. Psychopharmacology (Berl) 2008; 200(1): 39-50.
122. Tait DS, Brown VJ, Farovik A, Theobald DE, Dalley JW, Robbins TW. Lesions of the dorsal noradrenergic bundle impair attentional set-shifting in the rat. Eur J Neurosci 2007; 25: 3719-3724.
123. Bymaster FP, Katner JS, Nelson DL, et al. Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: a potential mechanism for efficacy in attention defi-cit/hyperactivity disorder. Neuropsychopharmacology 2002; 27: 699-711.
124. Hatcher PD, Brown VJ, Tait DS, et al. 5- HT6 receptor antagonists improve performance in an attentional set shifting task in rats. Psy-chopharmacology (Berl) 2005; 181: 253-259.
125. Burnham KE, Baxter MG, Bainton JR, et al. Activation of 5-HT(6) receptors facilitates attentional set shifting. Psychopharmacology (Berl) 2010; 208: 13-21.
126. Liston C, Miller MM, Goldwater DS, et al. Stress-induced alterations in prefrontal cortical dendritic morphology predict selective impairments in perceptual attentional set-shifting. J Neurosci 2006; 26: 7870-7874.
127. Bondi CO, Rodriguez G, Gould GG, Frazer A, Morilak DA. Chronic unpredictable stress induces a cognitive deficit and anxiety-like behavior in rats that is prevented by chronic antidepressant drug treatment. Neuropsychopharmacology 2008; 33: 320-331.
128. Danet M, Lapiz-Bluhm S, Morilak DA. A cognitive deficit induced in rats by chronic intermittent cold stress is reversed by chronic an-tidepressant treatment. Int J Neuropsychopharmacol 2010; 13: 997-1009.
129. Lapiz-Bluhm MD, Soto-Pina AE, Hensler JG, Morilak DA. Chronic intermittent cold stress and serotonin depletion induce deficits of reversal learning in an attentional set-shifting test in rats. Psychopharmacology (Berl), 2009; 202: 329-341.
130. Nikiforuk A. Selective blockade of 5-HT7 receptors facilitates attentional set- shifting in stressed and control rats. Behav Brain Res 2012; 226: 118-123.
131. Nikiforuk A, Popik P. Long-lasting cognitive deficit induced by stress is alleviated by acute administration of antidepressants. Psy-choneuroendocrinology 2011; 36: 28-39.
132. O'Leary OF, Bechtholt AJ, Crowley JJ, Hill TE, Page ME, Lucki I. Depletion of serotonin and catecholamines block the acute behavioral response to different classes of antidepressant drugs in the mouse tail suspension test. Psychopharmacology (Berl) 2007; 192: 357-371.
133. Bondi CO, Jett JD, Morilak DA. Beneficial effects of desipramine on cognitive function of chronically stressed rats are mediated by alpha1- adrenergic receptors in medial prefrontal cortex. Prog Neu-ropsychopharmacol Biol Psychiatry 2010; 34: 913-923.
134. Clarke HF, Walker SC, Dalley JW, Robbins TW, Roberts AC. Cognitive inflexibility after prefrontal serotonin depletion is behav-iorally and neurochemically specific. Cereb Cortex 2007; 17: 18-27.
135. Tait DS, Brown VJ. Difficulty Overcoming Learned Non-reward during Reversal Learning in Rats with Ibotenic Acid Lesions of Orbital Prefrontal Cortex. Ann N Y Acad Sci 2007; 1121: 407-420.
136. Naegeli KJ, O'Connor JA, Banerjee P, Morilak DA. Effects of milnacipran on cognitive flexibility following chronic stress in rats. Eur J Pharmacol 2013; 703: 62-66.
137. Baxter MG. Age-related effects on prefrontal cortical systems: translating between rodents, nonhuman primates, and humans. In: Bizon JL, Woods AG, ed.eds., Animal models of human cognitive aging. Humana Press: New York, 2009; pp. 59-72.
138. Harlow HF. The formation of learning sets. Psychol Rev 1949; 56: 51-65.
139. Duffaud AM, Killcross S, George DN. Optional-shift behaviour in rats: a novel procedure for assessing attentional processes in discrimination learning. Q J Exp Psychol (Hove) 2007; 60: 534-542.
140. Schoenbaum G, Nugent SL, Saddoris MP, Setlow B. Orbitofrontal lesions in rats impair reversal but not acquisition of go, no-go odor discriminations. Neuroreport 2002; 13: 885-890.
141. Boulougouris V, Dalley JW, Robbins TW. Effects of orbitofrontal, infralimbic and prelimbic cortical lesions on serial spatial reversal learning in the rat. Behav Brain Res 2007; 179: 219-228.
142. Maes JH, Damen MD, Eling PA. More learned irrelevance than perseveration errors in rule shifting in healthy subjects. Brain Cogn 2004; 54: 201-211.
143. Slabosz A, Lewis SJ, Smigasiewicz K, Szymura B, Barker RA, Owen AM. The role of learned irrelevance in attentional set-shifting impairments in Parkinson's disease. Neuropsychology 2006; 20: 578-588.